Literature DB >> 17023727

Sex-specific manifestations of Löfgren's syndrome.

Johan Grunewald1, Anders Eklund.   

Abstract

MOTIVATION: It has been debated whether patients need to have erythema nodosum to be classified as having Löfgren's syndrome. In this study, we have therefore in detail evaluated and compared a large number of patients with an acute onset of sarcoidosis and bilateral hilar lymphadenopathy (BHL), with or without erythema nodosum (EN). This study is important because it may lead to a more accurate definition of Löfgren's syndrome, and an exact phenotype of patients is crucial in modern medical research.
BACKGROUND: Löfgren's syndrome is commonly regarded as a distinct clinical entity.
METHODS: We have in detail evaluated a large group of patients (n = 150) with an acute onset of sarcoidosis with BHL, in most cases with fever, EN, and/or bilateral ankle arthritis or periarticular inflammation. Within this group, 87 patients had EN (EN positive), whereas 63 were without EN (EN negative), though with distinct symmetric ankle inflammation.
RESULTS: EN-positive and EN-negative patients were identical in every aspect except that there were significantly more women in the EN-positive group: 58 women (67%) in the EN-positive group compared with only 17 (27%) women in the EN-negative group (p < 0.0001). In all other aspects, such as age, smoking habits, seasonal clustering of disease onset, rate of positive biopsies, chest radiography, pulmonary function, bronchoalveolar lavage cell distributions including the typically increased CD4/CD8 ratio, and clinical development of the disease, the EN-positive and EN-negative groups were close to identical. The two groups were also identically strongly associated with HLA-DRB1*0301/DQB1*0201, with 60 (69.0%) and 44 (69.8%) patients having this particular HLA type in the EN-positive and EN-negative groups, respectively. Such patients recovered to the same degree-that is, at almost 100%.
CONCLUSIONS: We conclude that manifestations of Löfgren's syndrome differ between men and women, with EN found predominantly in women, whereas a marked periarticular inflammation of the ankles or ankle arthritis without EN is seen preferentially in men.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17023727      PMCID: PMC1899259          DOI: 10.1164/rccm.200608-1197OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  32 in total

1.  Erythema nodosum. A review of one hundred and fifteen cases.

Authors:  H GORDON
Journal:  Br J Dermatol       Date:  1961-11       Impact factor: 9.302

2.  Erythema nodosum.

Authors:  D G JAMES
Journal:  Br Med J       Date:  1961-03-25

3.  Primary pulmonary sarcoidosis. II. Clinical course and prognosis.

Authors:  S LOFGREN
Journal:  Acta Med Scand       Date:  1953

4.  The bilateral hilar lymphoma syndrome; a study of the relation to age and sex in 212 cases.

Authors:  S LOFGREN; H LUNDBACK
Journal:  Acta Med Scand       Date:  1952-03-19

5.  The bilateral hilar lymphoma syndrome; a study of the relation to tuberculosis and sarcoidosis in 212 cases.

Authors:  S LOFGREN; H LUNDBACK
Journal:  Acta Med Scand       Date:  1952-03-19

Review 6.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

Review 7.  Genetic aspects in sarcoidosis.

Authors:  M Luisetti; A Beretta; L Casali
Journal:  Eur Respir J       Date:  2000-10       Impact factor: 16.671

8.  Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.

Authors:  H Visser; K Vos; E Zanelli; W Verduyn; G M Th Schreuder; I Speyer; F C Breedveld; J M W Hazes
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

9.  Clinical characteristics of patients in a case control study of sarcoidosis.

Authors:  R P Baughman; A S Teirstein; M A Judson; M D Rossman; H Yeager; E A Bresnitz; L DePalo; G Hunninghake; M C Iannuzzi; C J Johns; G McLennan; D R Moller; L S Newman; D L Rabin; C Rose; B Rybicki; S E Weinberger; M L Terrin; G L Knatterud; R Cherniak
Journal:  Am J Respir Crit Care Med       Date:  2001-11-15       Impact factor: 21.405

10.  Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS).

Authors:  B A Rybicki; M C Iannuzzi; M M Frederick; B W Thompson; M D Rossman; E A Bresnitz; M L Terrin; D R Moller; J Barnard; R P Baughman; L DePalo; G Hunninghake; C Johns; M A Judson; G L Knatterud; G McLennan; L S Newman; D L Rabin; C Rose; A S Teirstein; S E Weinberger; H Yeager; R Cherniack
Journal:  Am J Respir Crit Care Med       Date:  2001-12-01       Impact factor: 21.405

View more
  24 in total

Review 1.  Sarcoidosis--scientific progress and clinical challenges.

Authors:  Edward S Chen; David R Moller
Journal:  Nat Rev Rheumatol       Date:  2011-07-12       Impact factor: 20.543

2.  T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis.

Authors:  Edward S Chen; Jan Wahlström; Zhimin Song; Matthew H Willett; Maria Wikén; Rex C Yung; Erin E West; John F McDyer; Ying Zhang; Anders Eklund; Johan Grunewald; David R Moller
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

3.  Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.

Authors:  Johan Grunewald; Boel Brynedal; Pernilla Darlington; Magnus Nisell; Kerstin Cederlund; Jan Hillert; Anders Eklund
Journal:  Respir Res       Date:  2010-02-26

Review 4.  [Musculoskeletal manifestations of sarcoidosis].

Authors:  P Korsten; G Chehab
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

5.  Neurotrophins and neurotrophin receptors in pulmonary sarcoidosis - granulomas as a source of expression.

Authors:  Charlotta Dagnell; Johan Grunewald; Marija Kramar; Helga Haugom-Olsen; Göran P Elmberger; Anders Eklund; Caroline Olgart Höglund
Journal:  Respir Res       Date:  2010-11-08

Review 6.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

7.  Variation in the lymphotoxin-alpha/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis.

Authors:  Kathryn E McDougal; M Daniele Fallin; David R Moller; Zhimin Song; David J Cutler; Lori L Steiner; Garry R Cutting
Journal:  J Invest Dermatol       Date:  2009-02-19       Impact factor: 8.551

8.  Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis.

Authors:  Jan Wahlström; Jörn Dengjel; Bengt Persson; Hüseyin Duyar; Hans-Georg Rammensee; Stefan Stevanović; Anders Eklund; Robert Weissert; Johan Grunewald
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

9.  Sarcoidosis Diagnostic Score: A Systematic Evaluation to Enhance the Diagnosis of Sarcoidosis.

Authors:  Alexandra N Bickett; Elyse E Lower; Robert P Baughman
Journal:  Chest       Date:  2018-05-17       Impact factor: 9.410

10.  Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Löfgren's syndrome.

Authors:  Annegret Fischer; Ruta Valentonyte; Almut Nebel; Michael Nothnagel; Joachim Müller-Quernheim; Manfred Schürmann; Stefan Schreiber
Journal:  J Mol Med (Berl)       Date:  2008-03-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.